News | Office of International Affairs

Weill Cornell Medicine Establishes Office of International Affairs, Led by Dr. Michael G. Stewart

February 21, 2020

Weill Cornell Medicine has established a new Office of International Affairs that will unify the institution’s portfolio of international activities and strategically plan future international collaborations. Dr. Michael G. Stewart, an esteemed clinician and leader, has been appointed senior associate dean for international affairs and affiliations and is leading both the Office of International Affairs and the Office of Affiliations, which...

Weill Cornell Medicine and Monash University Join Forces to Drive Global Health Research Innovation

September 15, 2026

Weill Cornell Medicine and Australia’s Monash University have expanded their relationship through a new Memorandum of Agreement supporting research and academic collaboration between the institutions.

The relationship developed following an October 2025 visit to WCM led by Monash University Vice-Chancellor and President, Professor Sharon Pickering. The delegation met with Dean Robert A. Harrington, as well as leaders across the institution. Discussions focused on topics such as the...

Weill Cornell Medicine Welcomes Shinshu University to Explore Education & Research Exchanges

September 2, 2026

A delegation from Shinshu University in Japan, led by Dr. Shinichi Yonekura, Vice President for International Affairs, visited Weill Cornell Medicine on September 2, 2026. The delegation also included Dr. Sachi Tanaka, Head of the Institute for Food Design and One Health, Dr. Mitsuru Hamano, Vice Director of the Center for Global Education and Collaboration, and Dr. Kanako Morohaku of the Animal Science Division.

During the meeting, Dr. Hamano provided an overview of Shinshu...

Weill Cornell Medicine Breast Cancer Team Visit American Hospital of Paris and Advance Joint Medical Second Opinion Program

June 18, 2026

Building on a long-standing collaboration, Weill Cornell Medicine and the American Hospital of Paris (AHP) developed and launched a Joint Medical Second Opinion (MSO) Program in the fall of 2025. The program is centered on a shared commitment to advancing patient care, allowing AHP patients to benefit from a joint tumor board discussion and medical second opinion in breast oncology.

In June 2026, an interdisciplinary group of WCM faculty traveled to Paris, France, for an in-person...

Weill Cornell Medicine and Tokushima University Formalize Partnership and Engage in Meaningful Research Exchange

March 24, 2026

Dr. Kiyoshi Fukui, Executive Advisor to the President of Tokushima University in Japan, visited Weill Cornell Medicine from March 24–27, 2026, in a multi-day program focused on advancing research initiatives. The visit was structured around WCM investigators with aligning interests at Tokushima University.

Over several days, Dr. Fukui met with faculty working across cardiovascular and metabolic disease, chronic inflammation, neurodegenerative disease, pulmonology, fibrosis, lymphatic...

American Hospital of Paris meets with Weill Cornell Medicine to Further Collaborations in Sports Medicine and Pediatrics

March 23, 2026

The American Hospital of Paris (AHP) visited Weill Cornell Medicine and the Hospital for Special Surgery from March 23–25, 2026, as part of the longstanding relationship between WCM and AHP. The delegation included Dr. Benoit Gallix, Chief Executive Officer, Dr. Jean-Louis Sotton, Chief Operating Officer, Dr. Laurent Aumont, Head of Sports Medicine, Dr. Jerome Deana, Chief Development Officer, Dr. Alain Gervaix, Head of Pediatrics, and Dr. Arnold Munnich, Pediatrician and Geneticist.

...

Weill Cornell Medicine Welcomes Global Hubs Partner Hong Kong University of Science and Technology

June 17, 2025

A delegation from the Hong Kong University of Science and Technology (HKUST), a member of Cornell Global Hubs, visited Weill Cornell Medicine on July 17, 2025, as the university was evaluating the addition of a new medical school in Hong Kong. The delegation included Professor Tim Cheng, Vice President for Research and Development, Professor Bert Shi, Special Advisor to the Vice President for Research and Development and Director of the Center for Aging Science, Professor Guojun Bu, Head of...

South Korea’s National Health Insurance Service Discuss Quality Healthcare Delivery with Leadership at Weill Cornell Medicine

June 16, 2025

South Korea's National Health Insurance Service (NHIS), led by Dr. Ki-Suck Jung, President, and Su-Kyoung Kim, Director General, visited Weill Cornell Medicine and NewYork-Presbyterian on June 16, 2025. The delegation also included Min-Woo Goo, Director, Kyoung-Hee Park and Jae-Geun Ryu, Deputy Directors, and Chan Hwangbo, Manager.

The delegation first met with Dr. Michael G. Stewart, Senior Associate Dean for International Affairs and Affiliations, and WCM's Office of International...

Dr. Warren Johnson Honored with Weill Award

June 4, 2025

Video of Weill Cornell Medicine Honors Dr. Warren Johnson

Dr. Warren Johnson, a professor emeritus of medicine and founding director of Weill Cornell Medicine’s Center for Global Health, has been awarded the institution’s Joan and Sanford I. Weill Exemplary Achievement Award.

...

six people standing in front of a building with a sign reading "Tuberculosis and Clinical Trial Unit (CTU) Laboratory"

Diagnose to Cure: Developing RNA-based TB Testing

April 25, 2025

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent antibiotics can eradicate the Mycobacterium tuberculosis bacteria. And in about...